Living With Metastasis: Avastin - How Do We Decide If A Drug Is Worth the Cost?
On Sunday, the New York Times ran an interesting article on Avastin, a drug that has been mentioned to me several times, as the latest breakthrough in the fight against metastatic cancer. Avastin (the generic name is Bevacizumab) is made by Genentech and is very expensive. The article described how some are calling into question whether... Read more



















